Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.8.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2017
Dec. 31, 2016
Assets    
Equity method investments $ 522,615 $ 363,297
Government receivables 519,485 526,481
Commercial receivables 473,452 515,756
Receivables held-for-sale 19,081  
Real estate 340,824 172,257
Investments 151,209 58,058
Cash and cash equivalents 57,274 29,428
Other assets 166,232 80,610
Total Assets 2,250,172 1,745,887
Liabilities    
Accounts payable, accrued expenses and other 25,645 25,219
Deferred funding obligations 153,308 170,892
Credit facility 69,922 283,346
Non-recourse debt (secured by assets of $1,545 million and $864 million, respectively) 1,210,861 692,091
Convertible notes 147,655  
Total Liabilities 1,607,391 1,171,548
Stockholders' Equity    
Preferred stock, par value $0.01 per share, 50,000,000 shares authorized, no shares issued and outstanding
Common stock, par value $0.01 per share, 450,000,000 shares authorized, 51,665,449 and 46,493,155 shares issued and outstanding, respectively 517 465
Additional paid in capital 770,983 663,744
Accumulated deficit (131,251) (92,213)
Accumulated other comprehensive income (loss) (1,065) (1,388)
Non-controlling interest 3,597 3,731
Total Stockholders' Equity 642,781 574,339
Total Liabilities and Stockholders' Equity $ 2,250,172 $ 1,745,887